Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Broadly cross-reactive HIV-1 Env-specific antibodies

Broadly cross-reactive HIV-1 Env-specific antibodies

US Patent 10280213 · Granted May 7, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cancer treatment using β-(1-3)-(1-4)-glucan2024
Method for preparing dihydroartemisinin bulk drug in single process2024
Organic wastewater treatment method based on multi-element co-doping TiO2 nano p2022
Broadly cross-reactive HIV-1-specific antibodies for prevention and treatment of2021
Method of generating tumor-specific T cells2021
Cancer treatment using beta-(1-3)-(1-4)-glucan2021
Method of generating tumor-specific T cells2018
Anti-HER2 and anti-IGF-IR BI-specific antibodies and uses thereof2016
Graphene nanoribbons and methods2016
Anti-IGF-IR antibodies and uses thereof2013
Human immunodeficiency virus type 1 (HIV-1)-neutralizing human single-chain anti2012
Identification of novel broadly cross-reactive neutralizing human monoclonal ant2010